Specific roles for the PI3K and the MEK-ERK pathway in IGF-1-stimulated chemotaxis, VEGF secretion and proliferation of multiple myeloma cells: study in the 5T33MM model

Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*

Jones, J. I. W., & Clemmons, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,488 · see citing works

Lymphocyte Homing and Homeostasis

Butcher, E. C., & Picker, L. J. (1996) · Science · doi:10.1126/science.272.5258.60 · Cited by 2,846 · see citing works

Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

Connolly, D. T., Heuvelman, D. M., Nelson, R. M., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., & Feder, J. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114322 · Cited by 1,265 · see citing works

The Somatomedin Hypothesis: 2001

Roith, D. L., Bondy, C. A., Yakar, S., Liu, J., & Butler, A. A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0419 · Cited by 1,258 · see citing works

Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)

Zimmermann, S., & Moelling, K. (1999) · Science · doi:10.1126/science.286.5445.1741 · Cited by 1,088 · see citing works

Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells

Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., & Semenza, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203781200 · Cited by 815 · see citing works

United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition)

(1998) · British Journal of Cancer · doi:10.1038/bjc.1998.1 · Cited by 650 · see citing works

Bone marrow angiogenesis and progression in multiple myeloma

Vacca, A., Ribatti, D., Roncali, L., Ranieri, G., Serio, G., Silvestris, F., & Dammacco, F. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb08304.x · Cited by 629 · see citing works

Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma

Vacca, A., Ribatti, D., Presta, M., Minischetti, M., Iurlaro, M., Ria, R., Albini, A., Bussolino, F., & Dammacco, F. (1999) · Blood · doi:10.1182/blood.v93.9.3064 · Cited by 593 · see citing works

Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion

Uchiyama, H., Barut, B., Mohrbacher, A., Chauhan, D., & Anderson, K. C. (1993) · Blood · doi:10.1182/blood.v82.12.3712.3712 · Cited by 419 · see citing works

Vascular endothelial growth factor triggers signaling cascades mediating multiple myeloma cell growth and migration

Podar, K., Tai, Y., Davies, F. E., Lentzsch, S., Sattler, M., Hideshima, T., Lin, B. K., Gupta, D. K., Shima, Y., Chauhan, D., et al. (2001) · Blood · doi:10.1182/blood.v98.2.428 · Cited by 412 · see citing works

Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation.

Bornfeldt, K., Raines, E. W., Nakano, T., Graves, L. M., Krebs, E. G., & Ross, R. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117081 · Cited by 409 · see citing works

Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation

Bakkus, M. H. C., Heirman, C., Riet, I. V., Camp, B. V., & Thielemans, K. (1992) · Blood · doi:10.1182/blood.v80.9.2326.2326 · Cited by 315 · see citing works

Signal Transduction by the Chemokine Receptor CXCR3

Bonacchi, A., Romagnani, P., Romanelli, R. G., Efsen, E., Annunziato, F., Lasagni, L., Francalanci, M., Serio, M., Laffi, G., Pinzani, M., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010303200 · Cited by 300 · see citing works

Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass

Weiner, O. D. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00310-1 · Cited by 284 · see citing works

Role of Phosphoinositide 3-Kinase in Activation of Ras and Mitogen-Activated Protein Kinase by Epidermal Growth Factor

Wennström, S., & Downward, J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.6.4279 · Cited by 279 · see citing works

Requirement of Phosphatidylinositol 3-Kinase in Focal Adhesion Kinase-promoted Cell Migration

Reiske, H. R., Kao, S.-C., Cary, L. A., Guan, J., Lai, J., & Chen, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12361 · Cited by 270 · see citing works

Roles of PI3Ks in leukocyte chemotaxis and phagocytosis

Stephens, L., Ellson, C. D., & Hawkins, P. T. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00311-3 · Cited by 258 · see citing works

The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses.

Tu, Y., Gardner, A. M., & Lichtenstein, A. K. (2000) · PubMed · Cited by 236 · see citing works

'Role of bone marrow stromal cells in the growth of human multiple myeloma

Caligaris‐Cappio, F., Bergui, L., Gregoretti, M. G., Gaïdano, G., Gaboli, M. P., M., S., Zallone, A., & Marchisio, P. (1991) · Blood · doi:10.1182/blood.v77.12.2688.bloodjournal77122688 · Cited by 234 · see citing works

The SDF‐1‐CXCR4 Axis Stimulates VEGF Secretion and Activates Integrins but does not Affect Proliferation and Survival in Lymphohematopoietic Cells

Kijowski, J., Baj‐Krzyworzeka, M., Majka, M., Reca, R., Marquez‐Curtis, L. A., Christofidou‐Solomidou, M., Janowska‐Wieczorek, A., & Ratajczak, M. Z. (2001) · Stem Cells · doi:10.1634/stemcells.19-5-453 · Cited by 224 · see citing works

Insulin and Insulin-like Growth Factor-I Induce Vascular Endothelial Growth Factor mRNA Expression via Different Signaling Pathways

Miele, C., Rochford, J. J., Filippa, N., Giorgetti‐Peraldi, S., & OBBERGHEN, E. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000805200 · Cited by 216 · see citing works

Vascular Endothelial Growth Factor-induced Migration of Multiple Myeloma Cells Is Associated with β1 Integrin- and Phosphatidylinositol 3-Kinase-dependent PKCα Activation

Podar, K., Tai, Y., Lin, B. K., Narsimhan, R. P., Sattler, M., Kijima, T., Salgia, R., Gupta, D. K., Chauhan, D., & Anderson, K. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109068200 · Cited by 180 · see citing works

Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines

Georgii‐Hemming, P., Wiklund, H., Ljunggren, Ö., & Nilsson, K. (1996) · Blood · doi:10.1182/blood.v88.6.2250.bloodjournal8862250 · Cited by 178 · see citing works

Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL/KaLwRij mice.

Radl, J., de Glopper, E., Schuit, H. R. E., & ZURCHER, C. (1979) · PubMed · Cited by 161 · see citing works

Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures

Lokhorst, H. M., Lamme, T., Smet, M. D., Klein, S. C., de Weger, R. A., Oers, R. H. J. V., & Bloem, A. C. (1994) · Blood · doi:10.1182/blood.v84.7.2269.2269 · Cited by 159 · see citing works

Organ involvement and phenotypic adhesion profile of 5T2 and 5T33 myeloma cells in the C57BL/KaLwRij mouse

Vanderkerken, K., Raeve, H. D., Goes, E., Meirvenne, S. V., Radl, J., Riet, I. V., Thielemans, K., & Camp, B. V. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.409 · Cited by 153 · see citing works

Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway

Ferlin, M., Noraz, N., Hertogh, C., Brochier, J., Taylor, N. N., & Klein, B. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02364.x · Cited by 153 · see citing works

Chemokine signalling: pivoting around multiple phosphoinositide 3‐kinases

Curnock, A. P., Logan, M. K., & Ward, S. G. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01345.x · Cited by 151 · see citing works

Insulinlike growth factor–I signaling in multiple myeloma: downstream elements, functional correlates, and pathway cross-talk

Qiang, Y., Kopantzev, E. P., & Rudikoff, S. (2002) · Blood · doi:10.1182/blood.v99.11.4138 · Cited by 149 · see citing works

The 5TMM series: a useful in vivo mouse model of human multiple myeloma

Asosingh, K., Radl, J., Riet, I. V., Camp, B. V., & Vanderkerken, K. (2000) · The Hematology Journal · doi:10.1038/sj.thj.6200052 · Cited by 143 · see citing works

PI 3-Kinases and PTEN

Comer, F. I., & Parent, C. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00765-1 · Cited by 132 · see citing works

Secretion of insulinlike growth factor I and insulinlike growth factor-binding proteins by murine bone marrow stromal cells.

Abboud, S. L., Bethel, C. R., & Aron, D. C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115327 · Cited by 107 · see citing works

Insulin-Like Growth Factor I-Triggered Cell Migration and Invasion Are Mediated by Matrix Metalloproteinase-91

Mira, E., Mañes, S., Lacalle, R. A., Márquez, G., & Martínez‐A, C. (1999) · Endocrinology · doi:10.1210/endo.140.4.6623 · Cited by 100 · see citing works

Idiopathic Paraproteinemia

Radl, J., de Glopper, E., Schuit, H. R. E., & ZURCHER, C. (1979) · The Journal of Immunology · doi:10.4049/jimmunol.122.2.609 · Cited by 100 · see citing works

Insulin-Like Growth Factor-1 Acts as a Chemoattractant Factor for 5T2 Multiple Myeloma Cells

Vanderkerken, K., Asosingh, K., Braet, F., Riet, I. V., & Camp, B. V. (1999) · Blood · doi:10.1182/blood.v93.1.235 · Cited by 91 · see citing works

In vivo induction of insulin-like growth factor-I receptor and CD44v6 confers homing and adhesion to murine multiple myeloma cells

Asosingh, K., Günthert, U., Bakkus, M. H. C., Raeve, H. D., Goes, E., Riet, I. V., Camp, B. V., & Vanderkerken, K. (2000) · PubMed · doi:10.5451/unibas-ep6481 · Cited by 74 · see citing works

Different Effects of Glucose Starvation on Expression and Stability of VEGF mRNA Isoforms in Murine Ovarian Cancer Cells

Zhang, L., Conejo-Garcia, J. R., Yang, N., Huang, W. C., Mohamed-Hadley, A. A., Yao, W., Benencia, F., & Coukos, G. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6710 · Cited by 66 · see citing works

Role of Phosphoinositide 3-Kinase in Monocyte Recruitment under Flow Conditions

Gerszten, R. E., Friedrich, E. B., Matsui, T., Hung, R. R., Li, L., Force, T. L., & Rosenzweig, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011235200 · Cited by 66 · see citing works

Prolonged Nuclear Retention of Activated Extracellular Signal-regulated Kinase 1/2 Is Required for Hepatocyte Growth Factor-induced Cell Motility

Tanimura, S., Nomura, K., Ozaki, K., Tsujimoto, M., Kondo, T., & Kohno, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202866200 · Cited by 60 · see citing works

Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes

Triggiani, M., Granata, F., Oriente, A., Gentile, M., Petraroli, A., Balestrieri, B., & Marone, G. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200201)32:1 · Cited by 59 · see citing works

The Involvement of Adhesion Molecules in the Biology of Multiple Myeloma

Riet, I. V., & Camp, B. V. (1993) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199309145751 · Cited by 57 · see citing works

Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.

Freund, G. G., Kulas, D. T., Way, B. A., & Mooney, R. A. (1994) · PubMed · Cited by 56 · see citing works

Selective initial in vivo homing pattern of 5T2 multiple myeloma cells in the C57BL/KalwRij mouse

Vanderkerken, K., Greef, C. D., Asosingh, K., Arteta, B., Veerman, M. D., Broek, I. V., Riet, I. V., Kobayashi, M., Smedsrød, B. H., & Camp, B. V. (2000) · British Journal of Cancer · doi:10.1054/bjoc.1999.1024 · Cited by 52 · see citing works

Murine 5T multiple myeloma cells induce angiogenesis in vitro and in vivo

Valckenborgh, E. V., Raeve, H. D., Devy, L., Blacher, S., Munaut, C., Noël, A., Marck, E. V., Riet, I. V., Camp, B. V., & Vanderkerken, K. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600137 · Cited by 51 · see citing works

Hepatocyte growth factor/scatter factor stimulates migration of rat mammary fibroblasts through both mitogen‐activated protein kinase and phosphatidylinositol 3‐kinase/Akt pathways

Delehedde, M., Sergeant, N., Lyon, M., Rudland, P. S., & Fernig, D. G. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02363.x · Cited by 50 · see citing works

IGF-I stimulates chemotaxis of human neuroblasts. Involvement of type 1 IGF receptor, IGF binding proteins, phosphatidylinositol-3 kinase pathway and plasmin system

Puglianiello, A., Germani, D., Rossi, P., & Cianfarani, S. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1650123 · Cited by 44 · see citing works

The F‐Actin Content of Multiple Myeloma Cells as a Measure of Their Migration

Menu, E., Braet, F., Timmers, M., Riet, I. V., Camp, B. V., & Vanderkerken, K. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04620.x · Cited by 20 · see citing works

MIP-1α Induces Activation of Phosphatidylinositol-3 Kinase That Associates with Pyk-2 and Is Necessary for B-Cell Migration

Rumsey, L. M., Teague, R. M., Benedict, S. H., & Chan, M. A. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5272 · Cited by 18 · see citing works

Controlling Cell Behavior Electrically: Current Views and Future Potential

McCaig, C., Rajnicek, A. M., Song, B., & Zhao, M. (2005) · Physiological Reviews · doi:10.1152/physrev.00020.2004 · Cited by 1,098 · see citing works

The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications

Podar, K., & Anderson, K. C. (2004) · Blood · doi:10.1182/blood-2004-07-2909 · Cited by 343 · see citing works

Obesity and cancer: existing and new hypotheses for a causal connection

Stone, T. W., McPherson, M., & Gail Darlington, L. (2018) · eBioMedicine · doi:10.1016/j.ebiom.2018.02.022 · Cited by 262 · see citing works

Hepatokines and metabolism: Deciphering communication from the liver

Jensen-Cody, S. O., & Potthoff, M. J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101138 · Cited by 252 · see citing works

Regulation of apoptosis by insulin-like growth factor (IGF)-I

Kooijman, R. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2006.02.002 · Cited by 201 · see citing works

IGF-1 receptor tyrosine kinase inhibition by the cyclolignan PPP induces G2/M-phase accumulation and apoptosis in multiple myeloma cells

Strömberg, T. (2005) · Blood · doi:10.1182/blood-2005-01-0306 · Cited by 158 · see citing works

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model

Menu, E., Jernberg‐Wiklund, H., Strömberg, T., Raeve, H. D., Girnita, L., Larsson, O., Axelson, M., Asosingh, K., Nilsson, K., Camp, B. V., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0293 · Cited by 145 · see citing works

Blockade of the MEK/ERK signalling cascade by AS703026, a novel selective MEK1/2 inhibitor, induces pleiotropic anti‐myeloma activity in vitro and in vivo

Kım, K., Kong, S., Fulciniti, M., Li, X., Song, W., Nahar, S., Burger, P., Rumizen, M. J., Podar, K., Chauhan, D., et al. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08127.x · Cited by 126 · see citing works

Leptin-induced growth of human ZR-75-1 breast cancer cells is associated with up-regulation of cyclin D1 and c-Myc and down-regulation of tumor suppressor p53 and p21WAF1/CIP1

Chen, C., Chang, Y., Liu, C., Chang, K., & Guo, I.-C. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9139-y · Cited by 120 · see citing works

Extravasation and homing mechanisms in multiple myeloma

Broek, I. V., Vanderkerken, K., Camp, B. V., & Riet, I. V. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9108-4 · Cited by 108 · see citing works

Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo

Xu, S., Menu, E., Becker, A. D., Van Camp, B., Vanderkerken, K., & Van Riet, I. (2012) · Stem Cells · doi:10.1002/stem.787 · Cited by 103 · see citing works

IGF-1 suppresses Bim expression in multiple myeloma via epigenetic and posttranslational mechanisms

De Bruyne, E., Bos, T. J., Schuit, F., Van Valckenborgh, E., Menu, E., Thorrez, L., Atadja, P., Jernberg-Wiklund, H., & Vanderkerken, K. (2010) · Blood · doi:10.1182/blood-2009-07-232801 · Cited by 103 · see citing works

Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor–induced DNA damage in vitro and in vivo in human multiple myeloma cells

Dai, Y., Chen, S., Pei, X., Almenara, J. A., Kramer, L. B., Venditti, C. A., Dent, P., & Grant, S. (2008) · Blood · doi:10.1182/blood-2008-05-159392 · Cited by 101 · see citing works

Hypoxia response and VEGF-A expression in human proximal tubular epithelial cells in stable and progressive renal disease

Rudnicki, M., Perco, P., Enrich, J., Eder, S., Heininger, D., Bernthaler, A., Wiesinger, M., Sárközi, R., Noppert, S.-J., Schramek, H., et al. (2009) · Laboratory Investigation · doi:10.1038/labinvest.2008.158 · Cited by 101 · see citing works

Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway

Chen, C., Chang, Y., Liu, C., Liu, T., Chang, K., & Guo, I.-C. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0027 · Cited by 91 · see citing works

CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma

Murray, M. E., Gavile, C. M., Nair, J. R., Koorella, C., Carlson, L. M., Buac, D., Utley, A. T., Chesi, M., Bergsagel, P. L., Boise, L., et al. (2014) · Blood · doi:10.1182/blood-2013-10-530964 · Cited by 91 · see citing works

Combination Mammalian Target of Rapamycin Inhibitor Rapamycin and HSP90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Has Synergistic Activity in Multiple Myeloma

Francis, L. K., Alsayed, Y. M., Leleu, X. P., Jia, X., Singha, U. K., Anderson, J. L., Timm, M., Ngo, H. T., Lu, G., Huston, A. J., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1331 · Cited by 91 · see citing works

Molecular Determinants of P2Y2 Nucleotide Receptor Function: Implications for Proliferative and Inflammatory Pathways in Astrocytes

Weisman, G. A., Wang, M., Kong, Q., Chorna, N., Neary, J. T., Sun, G. Y., González, F. A., Seye, C. I., & Erb, L. (2005) · Molecular Neurobiology · doi:10.1385/mn:31:1-3:169 · Cited by 86 · see citing works

Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells

Amit-Vazina, M., Shishodia, S., Harris, D., Van, Q., Wang, M., Weber, D., Alexanian, R., Talpaz, M., Aggarwal, B. B., & Estrov, Z. E. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602637 · Cited by 86 · see citing works

Germline Lysine-Specific Demethylase 1 ( LSD1/KDM1A ) Mutations Confer Susceptibility to Multiple Myeloma

Wei, X., Calvo-Vidal, M. N., Chen, S., Wu, G., Revuelta, M. V., Sun, J. H., Zhang, J., Walsh, M. F., Nichols, K. E., Vijai, J., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1900 · Cited by 85 · see citing works

Upregulation of miR-135b Is Involved in the Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients

Xu, S., Santini, G., Veirman, K. D., Broek, I. V., Leleu, X. P., Becker, A. D., Camp, B. V., Vanderkerken, K., & Riet, I. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0079752 · Cited by 82 · see citing works

Defining the role of TORC1/2 in multiple myeloma

Maiso, P., Liu, Y., Morgan, B. L., Azab, A. K., Ren, P., Martin, M. B., Zhang, Y., Yang, L., Sacco, A., Ngo, H. T., et al. (2011) · Blood · doi:10.1182/blood-2011-03-342394 · Cited by 77 · see citing works

Recent Updates on Obesity Treatments: Available Drugs and Future Directions

Dragano, N. R. V., Fernø, J., Diéguez, C., López, M., & Milbank, E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.04.034 · Cited by 72 · see citing works

Osteopontin and MMP9: Associations with VEGF Expression/Secretion and Angiogenesis in PC3 Prostate Cancer Cells

Gupta, A., Zhou, C. Q., & Chellaiah, M. A. (2013) · Cancers · doi:10.3390/cancers5020617 · Cited by 71 · see citing works

Insulin-like growth factor-I stimulates IL-10 production in human T cells

Kooijman, R., & Coppens, A. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0404248 · Cited by 71 · see citing works

The Microenvironment and Molecular Biology of the Multiple Myeloma Tumor

Lemaire, M., Deleu, S., Bruyne, E. D., Valckenborgh, E. V., Menu, E., & Vanderkerken, K. (2011) · Advances in cancer research · doi:10.1016/b978-0-12-386469-7.00002-5 · Cited by 70 · see citing works

Targeting the IGF‐1R using picropodophyllin in the therapeutical 5T2MM mouse model of multiple myeloma: Beneficial effects on tumor growth, angiogenesis, bone disease and survival

Menu, E., Jernberg‐Wiklund, H., Raeve, H. D., Leenheer, E. D., Coulton, L. A., Gallagher, O., Valckenborgh, E. V., Larsson, O., Axelson, M., Nilsson, K., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22845 · Cited by 69 · see citing works

The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model.

Menu, E., Asosingh, K., Indraccolo, S., Raeve, H. D., Riet, I. V., Valckenborgh, E. V., Broek, I. V., de Broek, I. V., Fujii, N., Tamamura, H., et al. (2006) · PubMed · Cited by 69 · see citing works

The role of the insulin-like growth factor-I receptor in malignancy: An update

Seccareccia, E., & Brodt, P. (2012) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2012.09.003 · Cited by 68 · see citing works

Plasma and tissue insulin-like growth factor-I receptor (IGF-IR) as a prognostic marker for prostate cancer and anti-IGF-IR agents as novel therapeutic strategy for refractory cases: A review

Özkan, E. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.07.002 · Cited by 67 · see citing works

Antibody targeting of the insulin-like growth factor I receptor enhances the anti-tumor response of multiple myeloma to chemotherapy through inhibition of tumor proliferation and angiogenesis

Wu, K., Zhou, L., Burtrum, D. B., Ludwig, D. L., & Moore, M. A. S. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0196-9 · Cited by 65 · see citing works

Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo

Xu, S., De Veirman, K., Evans, H., Santini, G. C., Vande Broek, I., Leleu, X., De Becker, A., Van Camp, B., Croucher, P., Vanderkerken, K., et al. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.182 · Cited by 64 · see citing works

The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential

Bieghs, L., Johnsen, H. E., Maes, K., Menu, E., Van Valckenborgh, E., Overgaard, M. T., Nyegaard, M., Conover, C. A., Vanderkerken, K., & De Bruyne, E. (2016) · Oncotarget · doi:10.18632/oncotarget.8982 · Cited by 61 · see citing works

Targeting Akt and Heat Shock Protein 90 Produces Synergistic Multiple Myeloma Cell Cytotoxicity in the Bone Marrow Microenvironment

Huston, A. J., Leleu, X. P., Jia, X., Moreau, A.-S., Ngo, H. T., Runnels, J. M., Anderson, J., Alsayed, Y. M., Roccaro, A. M., Vallet, S., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1299 · Cited by 60 · see citing works

Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non–COX-2 inhibitory analog of celecoxib

Kardosh, A., Soriano, N., Liu, Y., Uddin, J., Petasis, N. A., Hofman, F. M., Chen, T. C., & Schönthal, A. H. (2005) · Blood · doi:10.1182/blood-2005-07-2819 · Cited by 60 · see citing works

Apoptosis of Multiple Myeloma

Oancea, M., Mani, A., Hussein, M. A., & Almasan, A. (2004) · International Journal of Hematology · doi:10.1532/ijh97.04107 · Cited by 58 · see citing works

The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models

Deleu, S., Lemaire, M., Arts, J., Menu, E., Valckenborgh, E. V., King, P., Broek, I. V., Raeve, H. D., Camp, B. V., Croucher, P. I., et al. (2009) · Leukemia · doi:10.1038/leu.2009.121 · Cited by 57 · see citing works

Obesity and multiple myeloma: Emerging mechanisms and perspectives

Tentolouris, A., Ntanasis‐Stathopoulos, I., & Terpos, E. (2023) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2023.04.003 · Cited by 58 · see citing works

Novel targeted drugs for the treatment of multiple myeloma: from bench to bedside

Bruno, B., Giaccone, L., Rotta, M., Anderson, K. C., & Boccadoro, M. (2005) · Leukemia · doi:10.1038/sj.leu.2403905 · Cited by 54 · see citing works

Age‐related differences in insulin‐like growth factor‐1 receptor signaling regulates Akt/FOXO3a and ERK/Fos pathways in vascular smooth muscle cells

Li, M., Chiu, J., Gagne, J., & Fukagawa, N. K. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21507 · Cited by 54 · see citing works

Anti–β2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts

Yang, J., Zhang, X., Wang, J., Qian, J., Zhang, L., Wang, M. L., Kwak, L. W., & Yi, Q. (2007) · Blood · doi:10.1182/blood-2007-06-094417 · Cited by 52 · see citing works

Angiogenesis in Multiple Myeloma

Vacca, A., Ria, R., Reale, A., & Ribatti, D. (2013) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000353312 · Cited by 50 · see citing works

Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells

Baumann, P., Mandl–Weber, S., Emmerich, B., Straka, C., & Schmidmaier, R. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.06.020 · Cited by 50 · see citing works

Type I insulin-like growth factor receptor signaling in hematological malignancies

Vishwamitra, D., George, S. K., Shi, P., Kaseb, A. O., & Amin, H. M. (2016) · Oncotarget · doi:10.18632/oncotarget.12123 · Cited by 49 · see citing works

A Phase II Trial of AZD6244 (Selumetinib, ARRY-142886), an Oral MEK1/2 Inhibitor, in Relapsed/Refractory Multiple Myeloma

Holkova, B., Zingone, A., Kmieciak, M., Bose, P., Badros, A. Z., Voorhees, P. M., Baz, R., Korde, N., Lin, H.-Y., Chen, J.-Q., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1076 · Cited by 48 · see citing works

The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model

Caers, J., Günthert, U., Raeve, H. D., Valckenborgh, E. V., Menu, E., Riet, I. V., Camp, B. V., & Vanderkerken, K. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05886.x · Cited by 46 · see citing works

IGF-1 promotes multiple myeloma progression through PI3K/Akt-mediated epithelial-mesenchymal transition

Peng, Y., Li, F., Zhang, P., Wang, X., Shen, Y., Feng, Y., Jia, Y., Zhang, R., Hu, J., & He, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117503 · Cited by 42 · see citing works

Selinexor synergizes with dexamethasone to repress mTORC1 signaling and induce multiple myeloma cell death

Argueta, C. E., Kashyap, T., Klebanov, B., Unger, T. J., Guo, C., Harrington, S., Baloglu, E., Lee, M., Senapedis, W. T., Shacham, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.25368 · Cited by 45 · see citing works

Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma

Akhtar, S., Ali, T. A., Faiyaz, A., Khan, O. S., Raza, S. S., Kulinski, M., Omri, H. E., Bhat, A. A., & Uddin, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21145002 · Cited by 44 · see citing works

Targeting signalling pathways for the treatment of multiple myeloma

Podar, K., Hideshima, T., Chauhan, D., & Anderson, K. C. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.2.359 · Cited by 42 · see citing works

The impact of the bone marrow microenvironment on multiple myeloma (Review)

Hou, J., Wei, R., Qian, J., Wang, R., Fan, Z., Gu, C., & Yang, Y. (2019) · Oncology Reports · doi:10.3892/or.2019.7261 · Cited by 40 · see citing works

The role of the insulin-like growth factor 1 receptor axis in multiple myeloma

Menu, E., Valckenborgh, E. V., Camp, B. V., & Vanderkerken, K. (2009) · Archives of Physiology and Biochemistry · doi:10.1080/13813450902736583 · Cited by 37 · see citing works

Adrenocortical tumors and insulin resistance: What is the first step?

Altieri, B., Tirabassi, G., Casa, S. D., Ronchi, C. L., Balercia, G., Orio, F., Pontecorvi, A., Colao, A., & Muscogiuri, G. (2015) · International Journal of Cancer · doi:10.1002/ijc.29950 · Cited by 37 · see citing works

Bone Marrow Stromal Cells From Myeloma Patients Support the Growth of Myeloma Stem Cells

Feng, Y., Wen, J., Mike, P., Choi, D. S., Eshoa, C., Shi, Z.-Z., Zu, Y., & Chang, C.-C. (2010) · Stem Cells and Development · doi:10.1089/scd.2010.0010 · Cited by 38 · see citing works

Antitumour and antiangiogenic effects of Aplidin® in the 5TMM syngeneic models of multiple myeloma

Caers, J., Menu, E., Raeve, H. D., LePage, D., Valckenborgh, E. V., Camp, B. V., Álvarez, E., & Vanderkerken, K. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604388 · Cited by 36 · see citing works

Myeloma cells (5TMM) and their interactions with the marrow microenvironment

Menu, E., Asosingh, K., Riet, I. V., Croucher, P. I., Camp, B. V., & Vanderkerken, K. (2004) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2004.04.012 · Cited by 36 · see citing works

Serum microRNA-139-5p is downregulated in lung cancer patients with lytic bone metastasis

Xu, S., Yang, F., Liu, R., Li, X., Fan, H., Liu, J., Wei, S., Chen, G., Chen, J., & Da, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6316 · Cited by 33 · see citing works

EphrinB2/EphB4 Signaling Regulates DPSCs to Induce Sprouting Angiogenesis of Endothelial Cells

Gong, T., Xu, J., Heng, B. C., Qiu, S., Yi, B., Han, Y., Lo, E. C. M., & Zhang, C. (2019) · Journal of Dental Research · doi:10.1177/0022034519843886 · Cited by 34 · see citing works

Immunological Prognostic Factors in Multiple Myeloma

Bębnowska, D., Hrynkiewicz, R., Grywalska, E., Pasiarski, M., Sosnowska‐Pasiarska, B., Smarz-Widelska, I., Góźdź, S. S., Roliński, J., & Niedźwiedzka‐Rystwej, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073587 · Cited by 32 · see citing works

Enamel matrix derivative induces production of vascular endothelial cell growth factor in human gingival fibroblasts

Sakoda, K., Nakajima, Y., & Noguchi, K. (2012) · European Journal Of Oral Sciences · doi:10.1111/j.1600-0722.2012.00999.x · Cited by 32 · see citing works

Novel targets in solid tumors: MEK inhibitors.

Messersmith, W. A., Hidalgo, M. M., Carducci, M., & Eckhardt, S. G. (2006) · PubMed · Cited by 32 · see citing works

Role of Galectins in Multiple Myeloma

Storti, P., Marchica, V., & Giuliani, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122740 · Cited by 29 · see citing works

Cell non-autonomous regulation of cerebrovascular aging processes by the somatotropic axis

Bickel, M. A., Csík, B., Gulej, R., Ungvari, A., Nyúl‐Tóth, Á., & Conley, S. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1087053 · Cited by 28 · see citing works

Suppression of pro-metastasis phenotypes expression in malignant pleural mesothelioma by the PI3K inhibitor LY294002 or the MEK inhibitor UO126.

Cole, G. W., Alleva, A. M., Zuo, J. T., Sehgal, S., Yeow, W.-S., Schrump, D. S., & Nguyen, D. M. (2006) · PubMed · Cited by 26 · see citing works

A novel interaction between fibroblast growth factor receptor 3 and the p85 subunit of phosphoinositide 3-kinase: activation-dependent regulation of ERK by p85 in multiple myeloma cells

Salazar, L., Kashiwada, T., Krejčı́, P., Muchowski, P. J., Donoghue, D. J., Wilcox, W. R., & Thompson, L. M. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp116 · Cited by 22 · see citing works

miR-4286 is Involved in Connections Between IGF-1 and TGF-β Signaling for the Mesenchymal Transition and Invasion by Glioblastomas

Ho, K., Chen, P., Shih, C.-M., Lee, Y., Cheng, C., Liu, A.-J., Lee, C.-C., & Chen, K. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00977-1 · Cited by 19 · see citing works

Control of Apoptosis in Human Multiple Myeloma by Insulin‐like Growth Factor I (IGF‐I)

Jernberg‐Wiklund, H., & Nilsson, K. (2007) · Advances in cancer research · doi:10.1016/s0065-230x(06)97006-7 · Cited by 19 · see citing works

Reprint of: Recent Updates on Obesity Treatments: Available Drugs and Future Directions

Dragano, N. R. V., Fernø, J., Diéguez, C., López, M., & Milbank, E. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.08.009 · Cited by 18 · see citing works

H89 (N-[2-p-bromocinnamylamino-ethyl]-5-isoquinolinesulphonamide) induces autophagy independently of protein kinase A inhibition

Inoue, H., Hase, K., Segawa, A., & Takita, T. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.06.018 · Cited by 18 · see citing works

Dihydrotestosterone Inhibits Insulin-Stimulated Cyclin D2 Messenger Ribonucleic Acid Expression in Rat Ovarian Granulosa Cells by Reducing the Phosphorylation of Insulin Receptor Substrate-1

Kayampilly, P. P., & Menon, K. M. J. (2005) · Endocrinology · doi:10.1210/en.2005-0818 · Cited by 18 · see citing works

Targeting survival and cell trafficking in multiple myeloma and W aldenstrom macroglobulinemia using pan‐class I PI 3 K inhibitor, buparlisib

Şahin, İ., Azab, F., Mishima, Y., Moschetta, M., Tsang, B., Glavey, S. V., Manier, S., Zhang, Y., Sacco, A., Roccaro, A. M., et al. (2014) · American Journal of Hematology · doi:10.1002/ajh.23814 · Cited by 16 · see citing works

Stimulation of vasculogenesis and leukopoiesis of embryonic stem cells by extracellular transfer RNA and ribosomal RNA

Sharifpanah, F., Silva, S. D., Bekhite, M. M., Hurtado-Oliveros, J., Preissner, K. T., Wartenberg, M., & Sauer, H. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.10.423 · Cited by 16 · see citing works

Vitamin D3 induces mesenchymal-to-endothelial transition and promotes a proangiogenic niche through IGF-1 signaling

Chen, L., Samanta, A., Zhao, L., Dudley, N. R., Buehler, T., Vincent, R. J., Hauptman, J., Girgis, M., & Dawn, B. (2021) · iScience · doi:10.1016/j.isci.2021.102272 · Cited by 16 · see citing works

Therapeutic Enhancement of ER Stress by Insulin-Like Growth Factor I Sensitizes Myeloma Cells to Proteasomal Inhibitors

Tagoug, I., Jordheim, L. P., Herveau, S., Matera, E., Huber, A., Chettab, K., Manié, S. N., & Dumontet, C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3134 · Cited by 16 · see citing works

Fucoidan inhibits angiogenesis induced by multiple myeloma cells

Liu, F., Luo, G., Xiao, Q., Chen, L., Luo, X., Lv, J., & Chen, L. (2016) · Oncology Reports · doi:10.3892/or.2016.4987 · Cited by 15 · see citing works

Stimulation of invariant natural killer T cells by α‐Galactosylceramide activates the JAK ‐ STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model

Nur, H., Rao, L., Frassanito, M. A., Raeve, H. D., Ribatti, D., Mfopou, J. K., Valckenborgh, E. V., Bruyne, E. D., Vacca, A., Vanderkerken, K., et al. (2014) · British Journal of Haematology · doi:10.1111/bjh.13092 · Cited by 14 · see citing works

Growth hormone associated with treatment efficacy of immune checkpoint inhibitors in gastric cancer patients

Zhao, Y., Ji, Z., Li, J., Zhang, S., Wu, C., Zhang, R., & Guo, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.917313 · Cited by 13 · see citing works

Pathways to therapy resistance: The sheltering effect of the bone marrow microenvironment to multiple myeloma cells

Bhowmick, K., Suskil, M. V., Al‐Odat, O. S., Elbezanti, W. O., Jonnalagadda, S. C., Budak-Alpdoǧan, T., & Pandey, M. K. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33091 · Cited by 15 · see citing works

Obesity as a Possible Risk Factor for Progression from Monoclonal Gammopathy of Undetermined Significance Progression into Multiple Myeloma: Could Myeloma Be Prevented with Metformin Treatment?

Júnior, A. D. D. C., Zanette, D. L., Pericole, F. V., Saad, S. T. O., & Carvalheira, J. B. C. (2021) · Advances in Hematology · doi:10.1155/2021/6615684 · Cited by 13 · see citing works

MKP3 negatively modulates PDGF-induced Akt and Erk5 phosphorylation as well as chemotaxis

Razmara, M., Eger, G., Rorsman, C., Heldin, C., & Lennartsson, J. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.11.001 · Cited by 13 · see citing works

Antiproliferative effect of sphingosylphosphorylcholine in thyroid FRO cancer cells mediated by cell cycle arrest in the G2/M phase

Afrasiabi, E., Blom, T., Balthasar, S., & Törnquist, K. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.016 · Cited by 12 · see citing works

IGF2 derived from SH-SY5Y neuroblastoma cells induces the osteoclastogenesis of human monocytic precursors

Avnet, S., Salerno, M., Quacquaruccio, G., Granchi, D., Giunti, A., & Baldini, N. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.05.030 · Cited by 12 · see citing works

Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia-inducible factor-1α and insulin-like growth factor-1 mRNA expression

Rui, M., Huang, Z., Liu, Y., Wang, Z., Liu, R., Fu, J., & Huang, H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2407 · Cited by 12 · see citing works

Death Receptors in Multiple Myeloma and Therapeutic Opportunities

Mollinedo, F. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-564-0_25 · Cited by 12 · see citing works

Computational modeling of multiple myeloma interactions with resident bone marrow cells

Urdeitx, P., Mousavi, S. J., Avril, S., & Doweidar, M. H. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106458 · Cited by 10 · see citing works

Body-mass Index and Health

Önal, A. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73958 · Cited by 9 · see citing works

Myeloma Cells and Their Interactions With the Bone Marrow Endothelial Cells

Bruyne, E. D., Menu, E., Valckenborgh, E. V., Raeve, H. D., Camp, B. V., Riet, I. V., & Vanderkerken, K. (2007) · Current Immunology Reviews · doi:10.2174/157339507779802151 · Cited by 9 · see citing works

Exploring the therapeutic potential of MSC-derived secretomes in neonatal care: focus on BPD and NEC

Azad, T., Wu, F., Mao, J., Zhu, J., Wang, Y., Zhou, X., Hong, K., Xie, H., Qiu, X., Li, B., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04616-8 · Cited by 8 · see citing works

Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma

Pappa, C. A., Tsirakis, G., Psarakis, F. E., Kolovou, A., Tsigaridaki, M., Stafylaki, D., Sfiridaki, K., & Alexandrakis, M. G. (2012) · Medical Oncology · doi:10.1007/s12032-012-0363-0 · Cited by 7 · see citing works

Insulin-like Growth Factor (IGF) system and gastrointestinal stromal tumours (GIST): present and future.

Nannini, M., Biasco, G., Astolfi, A., Urbini, M., & Pantaleo, M. A. (2014) · PubMed · doi:10.14670/hh-29.167 · Cited by 6 · see citing works

Frizzled‐9 triggers actin polymerization and activates mechano‐transducer YAP to rescue simulated microgravity‐induced osteoblast dysfunction

Shi, Q., Gui, J., Sun, L., Song, Y., Na, J., Zhang, J., Fan, Y., & Zheng, L. (2023) · The FASEB Journal · doi:10.1096/fj.202300977r · Cited by 5 · see citing works

Quercetin induces dual specificity phosphatase 5 via serum response factor

Boonruang, K., Kim, I., Kwag, C., Ryu, J., & Baek, S. J. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0051 · Cited by 5 · see citing works

c‐Jun kinase mediates expression of VEGF induced at transcriptional level by Rac1 and Cdc42Hs but not by RhoA

Sanı́ger, M. L., Oya, R., Macías, D., Dominguez, J. N., Aránega, A. E., & Luque, F. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20801 · Cited by 5 · see citing works

Adipose Tissue-Derived Mediators in Multiple Myeloma: Linking Obesity to Bone Disease via Inflammatory Pathways

Stroe-Ionescu, A.-Ş., Tănase, A., Rotaru, I., Goanta, J. G., Pătraşcu, A. M., Boldeanu, M. V., Assani, M.-Z., Siloşi, I., Boldeanu, L., & Maria, D. T. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125618 · Cited by 4 · see citing works

Induction of necrosis in human myeloma cells by kigamicin.

Nakamura, M., Esumi, H., Lu, J., Mitsuya, H., & Hata, H. (2008) · PubMed · Cited by 4 · see citing works

Body Mass Index and Colorectal Cancer

Aykan, N. F., Artaç, M., & Özatlı, T. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.78617 · Cited by 4 · see citing works

Identifying transcriptomic profiles of iron–quercetin complex treated peripheral blood mononuclear cells from healthy volunteers and diabetic patients

Innuan, P., Sirikul, C., Anukul, N., Rolin, G., Dechsupa, N., & Kantapan, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-60197-1 · Cited by 3 · see citing works

Effects of mesenchymal stem cells from different sources on the biological functions of multiple myeloma cells

Li, Y., Liu, Y., Yang, X., Yang, B., Yang, B., Chen, J., Chen, J., Yuan, X., Xu, X., Liu, G., et al. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04222-8 · Cited by 3 · see citing works

The PI3K signaling pathway; from normal lymphopoiesis to lymphoid malignancies

Kashani, B., Zandi, Z., Pourbagheri‐Sigaroodi, A., Yousefi, A., Ghaffari, S. H., & Bashash, D. (2024) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2024.2350629 · Cited by 2 · see citing works

Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells

Qiang, Y., Yao, L., Tosato, G., & Rudikoff, S. (2003) · Blood · doi:10.1182/blood-2003-06-2066 · Cited by 143 · see citing works

Inhibiting the IGF-1 Receptor Tyrosine Kinase with Picropodophillin: An In Vitro and In Vivo Study in the 5T33MM Mouse Model.

Vanderkerken, K., Menu, E., Strömberg, T., Raeve, H. D., Asosingh, K., Camp, B. V., & Jernberg‐Wiklund, H. (2004) · Blood · doi:10.1182/blood.v104.11.640.640 · Cited by 1 · see citing works

Insulin-like growth factor I is a dual effector of multiple myeloma cell growth

Ge, N.-L., & Rudikoff, S. (2000) · Blood · doi:10.1182/blood.v96.8.2856 · Cited by 167 · see citing works

Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis

Giuliani, N., Lunghi, P., Morandi, F., Colla, S., Bonomini, S., Hojden, M., Rizzoli, V., & Bonati, A. (2004) · Leukemia · doi:10.1038/sj.leu.2403269 · Cited by 77 · see citing works

Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in vitro and in vivo study in the 5T33MM mouse model

Menu, E., Jernberg‐Wiklund, H., Strömberg, T., Raeve, H. D., Girnita, L., Larsson, O., Axelson, M., Asosingh, K., Nilsson, K., Camp, B. V., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0293 · Cited by 145 · see citing works